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To establish the relation between treadmill exercise testing 
and ambulatory ST segment monitoring in the detection of 
ischemia in patients with coronary artery disease, and to 
assess whether standard medical therapy affects any such 
relation, 277 patients with stable angina and angiographi- 
tally documented coronary artery disease were studied with 
treadmill exercise testing and 48 h ambulatory ST segment 
monitoring. One hundred forty-six patients (52%) were 
studied while receiving no routine antianginal therapy, and 
131 (48%) while receiving standard medical therapy. 
In 187 patients (67%) the exercise test was positive for 
ischemia. During 11,964 h of ambulatory monitoring, 881 
episodes of ischemia (645 [73%] silent) were recorded, of 
which 809 (92%) occurred in patients with a positive 
exercise test. The mean heart rate at the onset of ischemic 
episodes during ambulatory monitoring was significantly 
less than that at the onset of 1 mm ST segment depression 
during exercise testing (94.5 versus 105.9 beats/min, p < 
0.0001). However, the frequency of ambulatory ischemic 
episodes was strongly related to a positive exercise test (p < 
O.OOOl), and this relation was similar for both silent and 
painful ischemia (p < 0.0001 for both) and in patients who 
were and were not receiving therapy (p < 0.0001 for both). 
The total duration of ischemia was similarly related to a 
positive exercise test (p < 0.0001). Only one patient with a 
negative exercise test had frequent (>S/day) episodes of 
ischemia on ambulatory monitoring and had documented 
coronary artery spasm. 
Thus, exercise testing identifies the majority of patients 
likely to have significant ischemia during their daily activ- 
ities. The strong relation between ischemia in the formal 
exercise and ambulatory settings suggests that the underly- 
ing pathophysiologic mechanisms are similar, even though 
the heart rate at the onset of ischemia in the two settings is 
different. There is little indication to perform ambulatory 
ST segment monitoring in patients with a negative exercise 
test unless the history suggests coronary artery spasm. 
(J Am Co11 Cardioll989;14:1166-72) 
Ischemia in the ambulatory setting (the “total ischemic 
burden”) has generated considerable interest in recent 
times, particularly because it has been shown that the 
majority of episodes of significant ST segment change in 
patients with coronary disease occur in the absence of 
symptoms (l-3). Many studies have confirmed the ischemic 
nature of these episodes in patients with coronary artery 
disease (4,5), and silent and painful episodes of ischemia 
have been shown to be characteristically similar (1,6). It has 
been reported that the pathophysiologic mechanisms under- 
lying the development of ischemia in the ambulatory setting 
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may relate predominantly to a reduction in myocardial 
oxygen supply, rather than to an increase in myocardial 
oxygen demand, because the heart rate at the onset of 
ischemia in the ambulatory setting is significantly lower than 
that at the onset of 1 mm ST segment depression during 
exercise testing (7,8). If this is the case, one might not expect 
any particular relation between a positive exercise test and 
ischemia during the daily lives of patients, which, in turn, 
would have important investigative and therapeutic implica- 
tions. 
Clearly, if the mechanism of ischemia in the ambulatory 
setting is different from that of ischemia during exercise 
testing, ambulatory ST segment monitoring would be a 
complementary investigation for detecting ischemia in pa- 
tients with coronary artery disease. Furthermore, if ischemia 
during the daily lives of patients with coronary disease was 
related predominantly to alterations in coronary vasomotor 
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tone, it might be expected that calcium channel blocking 
agents would provide the greatest protective effect (9,10), 
and beta-adrenergic blocking agents might in certain circum- 
stances aggravate the ischemic situation as a result of 
unopposed alpha-vasoconstriction (11,12). 
We studied a large group of patients with coronary artery 
disease in an attempt to establish 1) whether there was any 
direct relation between the results of ambulatory ST segment 
monitoring and exercise testing, and 2) whether ambulatory 
ST segment monitoring contributed additional information to 
the results of exercise testing in detecting ischemia, as might 
be expected if it identified ischemia resulting from different 
mechanisms. The effects of standard antianginal therapy in 
altering any such relation between ambulatory monitoring 
and exercise testing were also assessed. 
Methods 
Study patients. Two hundred seventy-seven patients with 
angiographically documented coronary artery disease are 
included in this report. All patients had been referred for 
investigation of chest pain or a previous myocardial infarc- 
tion. There were 23 I men and 46 women, with a mean age of 
55.5 years (range 30 to 77). All had significant coronary 
artery disease (78 single, 89 double and 110 triple vessel 
disease). One hundred sixteen patients had had a previous 
myocardial infarction. All patients underwent treadmill ex- 
ercise testing and 48 h of ambulatory ST segment monitor- 
ing. Investigations were performed in 146 patients while they 
were receiving no routine antianginal therapy, and in 131 
when they were receiving standard antianginal therapy. 
Patients taking medication known to affect the ST segment, 
those with significant conduction disturbances and those 
unable to perform a treadmill exercise test were excluded 
from study. Also excluded were patients without at least one 
significant stenosis (>70%) of a major vessel. Abnormal rest 
ST/T wave changes were not considered an exclusion crite- 
rion for further study because, in the clinical setting, this is 
a common finding in patients presenting with chest pain. 
All patients underwent cardiac catheterization performed 
by either the Judkins or the Sones technique. All coronary 
angiograms were independently reported by one of two 
radiologists. A significant stenosis was defined as ~70% 
reduction in luminal diameter of a major vessel. 
Exercise testing. All patients underwent maximal symp- 
tom-limited treadmill exercise testing using the modified 
Bruce protocol (13). Electrocardiograms were recorded at 
the onset and every 3 min of exercise and also with the 
development of chest pain or significant ST segment depres- 
sion. A test was considered positive for ischemia if there was 
ST segment depression of ~1 mm in magnitude from base- 
line, which was planar or downsloping and persisted for 0.08 
s after the J point. Exercise was limited by the development 
of chest pain, breathlessness, exhaustion, and intermittent 
claudication, ventricular arrhythmias or hypotension. 
Ambulatory ST segment monitoring. All patients under- 
went 48 h of ambulatory electrocardiographic (ECG) moni- 
toring with pregelled electrodes to record two bipolar leads, 
anterior lead CM, and an inferior lead. The sites and method 
of application of these electrodes have been reported previ- 
ously (14). Two channel ECG recordings were then obtained 
on magnetic tape with use of a frequency-modulated dual 
channel recorder (Oxford Medilog 2, frequency response 
0.05 to 40 Hz). This system has adequate frequency response 
to accurately record and display the ST segment. The tapes 
were then visually analyzed at 60 to 120 times normal speed 
using an Oxford Medilog MA20 scanner, and all printouts 
were at 25 mm/s. Significant ST segment depression was 
defined as a planar or downsloping ST segment shift of ~1 
mm in magnitude from baseline measured 0.08 s after the J 
point and persisting for >30 s. Significant ST segment 
elevation was defined as rl mm upward shift of the ST 
segment at the J point compared with the recording at rest. 
Changes in T wave vector were not regarded as evidence of 
myocardial ischemia unless they were accompanied by sig- 
nificant ST segment changes. 
During the period of ambulatory monitoring, all patients 
kept a detailed angina diary, recording the time of each 
episode of pain, the activity at the onset of symptoms and 
the requirement for nitroglycerin. An event marker on the 
ambulatory monitor was pressed at the onset of symptoms. 
This marked the magnetic tape so that the ECG playback 
would automatically display the ECG at that time. All 
patients were encouraged to continue with their normal daily 
activities during the period of monitoring. 
Antianginal medications. One hundred thirty-one patients 
(48%) underwent investigation while receiving standard an- 
tianginal therapy. This consisted of a beta-adrenergic block- 
ing agent (n = 1041, a calcium channel blocking agent (n = 
86) and nitrates (n = 62), either singly (n = 38) or in various 
combinations (n = 93), in addition to nitroglycerin as re- 
quired. A further 146 patients were studied while taking no 
routine antianginal medication. In this group, those whose 
medications were stopped for the purposes of study had 
taken no routine therapy for at least 48 h; the others were 
studied before regular treatment was instituted. They took 
nitroglycerin as required, but not prophylactically during the 
study period. 
Statistical analysis. The paired t test was used to compare 
the heart rates at the onset of 1 mm ST segment depression 
on exercise testing with the mean heart rate at the onset of 
ischemia during ambulatory monitoring. The Mann-Whitney 
U test was used to compare the frequency and duration of 
ischemic episodes per 24 h in patients with a positive 
exercise test and those with a negative exercise test. 
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Figure 1. Histogram showing the relation between the mean fre- 
quency of total ischemic episodes/24 h on ambulatory ECG moni- 
toring in patients with a positive (t ve) and negative (-ve) exercise 
(ex) test for ischemia. 
Results 
Heart rate changes. The mean heart rate at the onset of 
ischemic episodes on ambulatory monitoring was compared 
with that at the onset of 1 mm ST segment depression during 
exercise testing. The heart rate at the onset of ischemia 
during ambulatory monitoring was significantly less than that 
during exercise (94.5 versus 105.9 beats/min, p < O.OOOl), 
and this difference was similar for both silent (93.8 versus 
106.8 beats/min, p < 0.0001) and painful (96.2 versus 103.2 
beatslmin, p < 0.001) episodes of ischemia, and in patients 
who were not (99.2 versus 109.9 beatslmin, p < 0.0001) and 
who were (86.1 versus 100.4 beats/min, p < 0.0001) receiving 
therapy. 
positive exercise test (N.187) negative exercise test (N&O) 
Ambulatory monitoring and exercise testing (Fig. 1 and 2). 
One hundred eighty-seven patients (67%) had a positive 
exercise test for ischemia, and 881 ischemic episodes were 
recorded during 11,964 h of ST segment monitoring, of 
which 645 episodes (73%) were clinically silent. Figure 1 
shows the relation between the results of exercise testing 
and the mean frequency of total ischemia on ambulatory 
monitoring in the 277 patients. Eight hundred nine episodes 
(92%) of ischemia recorded during the period of ambulatory 
monitoring occurred in patients with a positive exercise test; 
only 72 episodes (8%) occurred in patients with a negative 
exercise test. The frequency of total ischemic episodes per 
24 h was strongly related to a positive exercise test (p < 
0.0001). 
Figure 2 shows the frequency distribution of total isch- 
emit episodes in the 187 patients with a positive and the 90 
patients with a negative exercise test. Only one patient with 
a negative exercise test had frequent (>Yday) ischemic 
episodes, and this patient had documented coronary artery 
spasm. In the absence of coronary spasm, 88 patients with a 
negative exercise test had a total of 51 episodes of ischemia 
(5.7%) of a mean duration of 7.5 min124 h during 3,861 h of 
monitoring. 
Role of antianginal therapy (Fig. 3). We also investigated 
the relation between ischemia on ambulatory monitoring and 
the results of exercise testing in 146 patients who were not 
and 131 patients who were receiving routine antianginal 
therapy. Although the frequency of ischemic episodes in the 
group receiving standard therapy was less than that in the 
group not receiving therapy, there was no alteration in the 
overall relation between ischemic episodes on ambulatory 
monitoring and a positive or negative exercise test. The 
frequency of ischemic episodes was again significantly re- 
lated to a positive exercise test in both groups (p < 0.0001, 
Figure 2. Pie charts showing the frequency distribution 
of total ischemic episodes/24 h on ambulatory ECG 
monitoring in 187 patients with a positive exercise test 
(left) and 90 patients with a negative test (right). 
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Figure 3. Histograms demonstrating the relation between the fre- 
quency of total ischemic episodes/24 h on ambulatory ECG moni- 
toring and a positive (tve) or negative (-ve) exercise (ex) test in 146 
patients not receiving routine antianginal therapy (top) and 131 
patients receiving such therapy (bottom). 
Figure 4. Histograms showing the relation between the frequency 
of silent (top) and painful (bottom) ischemic episodes on ambulatory 
ECG monitoring and a positive (tve) or negative (-ve) exercise 
(ex) test. 
for both). There was a significant relation between the 
frequency of total ischemic episodes and stage to ischemia 
during exercise testing in both the group not receiving 
therapy (p < 0.001) and those receiving standard medical 
therapy (p < 0.05) when comparing patients whose exercise 
test was positive at <6 and >9 min. 
Silent/painful ischemia and exercise testing (Fig. 4). The 
relation between both silent (n = 645) and painful (n = 236) 
episodes of ischemia and a positive or negative exercise test 
was assessed. Painful and silent ischemia were equally 
strongly related to a positive exercise test (p < 0.0001 for 
both). 
Duration of ischemia and exercise testing. Figure 5 dem- 
onstrates the relation between the total duration of ischemic 
episodes124 h and a positive or negative exercise test in the 
overall group of 277 patients and in the two subgroups (146 
patients not receiving and 131 patients receiving therapy). 
The total duration of ischemic episodes/24 h was similarly 
related to a positive exercise test in all groups (p < 0.0001 for 
all three groups). 
Sensitivity of ambulatory monitoring and exercise testing. 
Exercise testing had a sensitivity of 67% for detecting 
coronary artery disease and ambulatory ST segment moni- 
toring a sensitivity of 54%. The addition of the information 
from 11,964 h of ambulatory ST segment monitoring in- 
creased the sensitivity of exercise testing from 67% to 74% 
for the combined investigations in detecting ischemia. 
Discussion 
Role of alterations in vasomotor tone in ambulatory isch- 
emia. From this study, it would appear that the heart rate at 
the onset of ischemia in the ambulatory setting is, indeed, 
less than that at the onset of 1 mm ST segment depression 
during formal exercise testing, and this is true of both silent 
and painful episodes of ischemia. For many years, angina 
was assumed to result from an imbalance between myocar- 
dial oxygen supply and demand across a fixed coronary 
stenosis. This belief was tempered by reports (15-17) that 
reduction in myocardial blood flow due to coronary spasm at 
the site of “fixed stenosis” was responsible for many isch- 
emit syndromes, and the demonstration (18) that the major- 
ity of coronary stenoses had an arc of normal arterial wall 
capable of dilation and constriction. Mudge et al. (19) 
showed that patients with stable exertional angina may 
manifest episodic vasoconstriction superimposed on fixed 
coronary lesions, and Yasue et al. (20) reported that there is 
a circadian pattern of coronary tone with a tendency to 
increased vasoconstriction in the morning. With the wide- 
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Figure 5. Histograms demonstrating the relation between the mean 
total duration of ischemic episodes on ambulatory ECG monitoring 
and a positive (tve) or negative (-ve) exercise (ex) test in 146 
patients not receiving antianginal therapy (top), 131 patients receiv- 
ing such therapy (middle) and all 277 patients studied (bottom). 
spread use of ambulatory ST segment monitoring, it has 
been reported (1,2,4,8,21,22) that the heart rate at the onset 
of daily ischemia is considerably less than that at the onset of 
exercise ischemia, as shown in this study. It has also been 
reported (4) that heart rate does not increase significantly 
before the majority of such ischemic episodes. 
These findings have led many investigators to suggest that 
the primary underlying pathophysiologic mechanism of am- 
bulatory ischemia is a reduction in myocardial oxygen 
supply due to alterations in coronary vasomotor tone. 
Quyyumi et al. (14) previously showed that a small but 
significant increase in heart rate precedes the majority of 
ischemic episodes during the daily lives of patients, and we 
have confirmed this finding (1). Although this discrepancy in 
heart rates between the two tests cannot be ignored, it may 
be that the method of assessing ischemia during exercise 
testing contributes partly to the differences in heart rates; the 
identification of 1 mm ST segment depression by performing 
ECGs only every 1 or 3 min or when significant ischemia 
appears to be present may obscure the true onset of isch- 
emia. It has also been shown that, although the heart rate 
may not increase significantly before the onset of ischemic 
episodes during mental stress and other daily activities, 
there is an increase in systolic and diastolic blood pressure, 
which results in an increase in myocardial oxygen demand 
(23). Deanfield et al. (24) also showed that systolic blood 
pressure at the onset of spontaneous ischemic episodes 
mirrors that at the onset of exercise-induced ischemia. Thus, 
assessment of underlying pathophysiologic mechanisms 
solely on the basis of the change in heart rate may be flawed. 
Role of beta-blockade in the mechanism of ambulatory 
ischemia. We previously showed (25) in subsets of patients 
that atenolol, a selective beta-adrenergic blocking agent with 
no coronary vasodilating activity, significantly reduces the 
frequency of ischemic episodes; others (26,27) have reported 
similar effects with other beta-blocking agents. In a recent 
multicenter randomized study of patients with angina, Stone 
et al. (28) reported that the addition of a calcium antagonist 
to a beta-blocker or nitrate, or both, had no effect on any 
measure of ambulatory ischemia in patients with classic 
exertional angina, and noted that episodic vasoconstriction 
may not be the only mechanism responsible for episodes of 
ambulatory ischemia. Furthermore, in a randomized study 
of metoprolol, nifedipine and their combination in chronic 
stable angina, Egstrup (29) showed that metoprolol signifi- 
cantly reduced the frequency and duration of ischemic 
episodes, and reported that the drug acted by reducing 
myocardial oxygen demand even during ischemic episodes 
observed in daily life, where impairments of myocardial 
oxygen supply are suspected. The benefits shown from 
beta-blockade in modifying transient ischemic episodes (25- 
3 1) do not support the concept that a reduction in myocardial 
oxygen supply plays a predominant role in transient isch- 
emit episodes. In contrast, beta-blockade may reduce myo- 
cardial oxygen demand and thus make transient reductions 
in oxygen supply due to alterations in coronary vasomotor 
tone more tolerable (29). Whatever the underlying patho- 
physiologic mechanisms of ischemia are, in either the am- 
bulatory or the formal exercise test setting, the relation 
between ischemia during exercise testing and during every- 
day activities suggests that the underlying mechanisms are 
similar, complex and likely to be multifactorial. 
Ambulatory ECG monitoring versus exercise testing for 
identifying ischemia. Although ambulatory monitoring sys- 
tems that faithfully reproduce the ST segment are becoming 
increasingly available, they are expensive and not freely 
available for routine clinical use. This study shows that we 
can identify the large majority of patients likely to have 
ischemia in the ambulatory setting by performing a standard 
exercise test, and that ambulatory monitoring adds little 
further information for detecting ischemia. In addition, 
whereas exercise testing had a sensitivity of 67% for the 
diagnosis of coronary artery disease, ambulatory ST seg- 
ment monitoring had a sensitivity of only 54%. Campbell et 
al. (22) reported a 54% sensitivity for ambulatory monitoring 
in the detection of ischemia, and noted that, in those with a 
negative exercise test, there were no ischemic episodes. In a 
study of 210 patients with stable angina, Tzivoni et al. (21) 
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reported that only 3 patients with a negative exercise test 
had evidence of ischemia on ambulatory monitoring. 
Quyyumi et al. (32) reported that ambulatory monitoring 
increases the sensitivity of exercise testing from 73% to 77% 
for the combined investigations. We have shown that despite 
almost 12,000 h of ambulatory monitoring, the sensitivity of 
exercise testing was increased by only 7% (to 74%) for the 
combined investigations in the detection of ischemia. 
Prognosis of ambulatory iscbemia. With continued re- 
search on ischemia during everyday activities, the quantifi- 
cation of ischemia may assume prognostic importance. Al- 
though silent myocardial ischemia in the setting of unstable 
angina or after myocardial infarction is associated with an 
adverse prognosis (33,34), we do not know the prognostic 
significance of ischemia in the ambulatory setting in patients 
with stable angina or whether medical therapy influences 
that prognosis. Recent evidence (35) suggests that in patients 
with coronary artery disease and a positive exercise test for 
ischemia, those with additional evidence of ischemia on 
ambulatory monitoring have an adverse prognosis compared 
with that in patients without ambulatory ischemia. If this 
were demonstrated in large scale trials, there would clearly 
be an indication to perform ambulatory ST segment moni- 
toring to supplement the results of a positive exercise test 
and allow for risk stratification. 
Diagnostic value of ambulatory ECG monitoring. Little 
diagnostic benefit is derived from performing ambulatory ST 
segment monitoring in patients with a negative exercise test 
(except in those with a history suggestive of coronary artery 
spasm or in patients who are unable to perform a meaningful 
exercise test). Also, the relation between ischemia in the 
ambulatory setting and that during exercise testing is pre- 
served in patients receiving standard medical therapy. 
Again, for this group of patients, ambulatory monitoring 
appears to add little information to the results of exercise 
testing for identifying ischemia. Few patients receiving stan- 
dard medical therapy were found to have frequent ischemia 
during their daily activities, attesting to the fact that standard 
medications are effective in treating the total ischemic bur- 
den (36). 
Previous reports. Epstein et al. (37) previously suggested 
that patients with no ischemic changes during exercise or 
with ischemia only at high levels of exercise, rarely have 
silent ischemia on ambulatory monitoring. We (I) confirmed 
this finding in patients who were not receiving routine 
therapy, showing a strong relation between the frequency of 
silent ischemia and stage to 1 mm ST segment depression on 
exercise testing. This relation also exists when comparing 
the frequency of total ischemic episodes with stage to 1 mm 
ST segment depression on exercise testing in groups with 
and without routine antianginal therapy when comparisons 
are made between those patients with a positive test at <6 
and >9 min of exercise. Quyyumi et al. (14) and Campbell et 
al. (22) also showed a significant relation between time to 
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onset of ischemia during exercise testing and frequency and 
duration of ambulatory ischemic episodes in patients with 
stable angina, and both reported the infrequency or absence 
of daily ischemic episodes in patients with a negative exer- 
cise test. Vaghaiwalla Mody et al. (38) reported no signifi- 
cant correlation between time to onset of ischemia during 
exercise testing and total duration of ischemia on ambulatory 
monitoring; however, they note that their study group did 
not have uniformly proved coronary artery disease, which 
may have had a bearing on the correlation between manifes- 
tations of ischemia during the exercise test and those docu- 
mented during ambulatory monitoring. They commented 
that the sensitivity and predictive accuracy of ambulatory 
ST segment monitoring was low, and that the quantification 
of the total ischemic burden by this method is of little 
diagnostic value in identifying the presence of coronary 
disease. 
Implications. Our findings suggest that it is possible to 
assess the efficacy of different drug regimens by performing 
standard exercise testing. Although further work is neces- 
sary, it is likely that a drug that eliminates or significantly 
delays the onset of ischemia during exercise testing will 
have a beneficial effect on the frequency and duration of 
silent and painful ischemia during the patient’s daily activi- 
ties. When investigating the prognostic implications and 
other aspects of silent ischemia and the total ischemic 
burden, it is probable that a positive exercise test at a 
relatively low work load will have to be a prerequisite for 
inclusion in such studies. It is noteworthy that, despite the 
proposal that the pathophysiologic mechanisms of ambula- 
tory ischemia result from different mechanisms from those 
causing ischemia during exercise testing, many investigators 
(3,4,8,24,39) have considered only patients with a positive 
exercise test when assessing the characteristics of ambula- 
tory ischemia. 
Conclusions. Silent and painful episodes of myocardial 
ischemia in the ambulatory setting appear to have underlying 
pathophysiologic mechanisms similar to those causing isch- 
emia during standard exercise testing. Ischemic episodes 
during the daily lives of patients with coronary artery disease 
almost invariably occur in those with a positive exercise test, 
whether those patients are studied with or without antiangi- 
nal therapy, and such episodes are rare and of short duration 
in those with a negative test. Ambulatory ST segment 
monitoring adds little to the results of exercise testing in 
detecting ischemia. There is little indication to perform 
ambulatory ST segment monitoring in patients with a nega- 
tive exercise test, except in patients who have a history 
suggestive of coronary artery spasm. 
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